Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Carillon

Carillon Eagle Small Cap Growth Fund Class C (HSCCX)

Ticker HSCCX · Since 1995-04-03 · · Holdings as of Jun 30, 2026

Expense ratio
1.87%$187/yr per $10k
5-yr return
+0.5%annualized
1-yr return
+10.7%as of Dec 2025
Net assets
$498.1Mall share classes
Holdings
108

Bottom line

Is HSCCX a good fund? The bottom line

HSCCX is the Class C share class of Carillon Eagle Small Cap Growth Fund, a managed small-cap mutual fund from Carillon.

Its expense ratio is 1.87% — about $187 a year on every $10,000 invested, more expensive than 92% of small-cap funds we track.

It returned +10.7% over one year, +0.5% a year over five years, +7.5% a year over ten (as of Dec 31, 2025, per its prospectus).

With $498 million in net assets and 108 holdings, its largest position is BrightSpring Health Services I (2.6%) and the top 10 make up 19.1% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.87%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What HSCCX invests in

The Carillon Eagle Small Cap Growth Fund (Eagle Small Cap Growth Fund or the fund) seeks long-term capital appreciation.

During normal market conditions, the Eagle Small Cap Growth Fund seeks to achieve its objective by investing at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in the stocks of small-capitalization companies. The funds portfolio managers consider small-capitalization companies to be those companies that, at the time of initial purchase, have a market capitalization equal to or less than the largest company in the Russell 2000 Growth Index during the most recent 12-month period (approximately $32.4 billion during the 12-month period ended December 31, 2025). The fund is not required to sell equity securities whose market values appreciate or depreciate outside this market capitalization range. When making their investment decisions, the portfolio managers generally focus on investing in the dividend paying equity securities, generally common…

From the fund's prospectus (filed Apr 28, 2026).

HSCCX performance

Average annual total returns
1 yr5 yr10 yr
HSCCX+10.7%+0.5%+7.5%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full HSCCX performance history →

What HSCCX costs

On a $10,000 investment, HSCCX's 1.87% expense ratio costs about $187 a year. The prospectus estimates $2,190 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full HSCCX fee table →

HSCCX top 10 holdings

#Holding% of fund
1BrightSpring Health Services I BTSG2.64%
2First American Government Obli2.25%
3Dycom Industries Inc DY2.19%
4Archrock Inc AROC1.95%
5Solstice Advanced Materials In SOLS1.77%
6RB Global Inc RBA1.70%
7PJT Partners Inc PJT1.69%
8Mercury Systems Inc MRCY1.66%
9SiTime Corp SITM1.63%
10Littelfuse Inc LFUS1.61%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 19.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to HSCCX

More funds like HSCCX →

HSCCX FAQ

What is the expense ratio of HSCCX?
HSCCX's expense ratio is 1.87%, which works out to about $187 a year for every $10,000 invested. The prospectus estimates total costs of $2,190 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is HSCCX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.87%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does HSCCX hold?
HSCCX's largest holdings are BrightSpring Health Services I (2.6%), First American Government Obli (2.3%), Dycom Industries Inc (2.2%), Archrock Inc (2.0%), Solstice Advanced Materials In (1.8%). It holds 108 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is HSCCX's 5-year return?
HSCCX returned +0.5% a year over the five years ending Dec 31, 2025, and +7.5% a year over ten years. Past performance does not guarantee future results.
Does HSCCX have a sales load?
No. HSCCX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages HSCCX?
HSCCX is offered by Carillon through Carillon Series Trust.